Search filters
Telephone outage

Telephone outage

22/01/2025

Due to a malfunction, we are currently not reachable by telephone.

For any questions you can send an email to...

Update Reimbursement Scheme Metoject®

Update Reimbursement Scheme Metoject®

15/11/2024

From January 1, 2025 the use of Metoject Pen® 7.5mg will be fully reimbursed by the Health Insurer. For this reason the...

Reimbursement Scheme Mounjaro KwikPen® for the indication Diabetes Mellitus type 2

Reimbursement Scheme Mounjaro KwikPen® for the indication Diabetes Mellitus type 2

06/11/2024

The health insurer does not fully reimburse Mounjaro KwikPen for the indication Diabetes Mellitus type 2. The producer of this...

Reimbursement Scheme Veoza®

Reimbursement Scheme Veoza®

01/05/2024

Reimbursement Scheme for VEOZA® (fezolinetant) 45 mg for the treatment of moderate to severe vasomotor symptoms (VMS) associated...

Update Reimbursement Scheme Elvanse®

Update Reimbursement Scheme Elvanse®

17/03/2024

TBR Nederland hereby informs you that from now on the conditions regarding the Reimbursement Scheme Elvanse® 20 mg, 30 mg, 40 mg,...

You are currently offline. Some pages or content may fail to load.